Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2025-12-24 @ 2:06 PM
NCT ID:
NCT00310895
Eligibility Criteria:
Inclusion Criteria:
* 18 years of age or older
* Male or female
* Measurable or evaluable solid tumor malignancy
* Relapsed, refractory, locally advanced, or metastatic disease
* Disease refractory to or not amenable to standard therapy
* Karnofsky performance status 70-100%
* Life expectancy 3 months or greater
Exclusion Criteria:
* Pregnant or lactating women
* Primary central nervous system(CNS) malignancy or active CNS metastases
* Hematologic malignancy
* Chemotherapy within 4 weeks prior to study
* Mitomycin C, nitrosoureas within 6 weeks prior to study
* High dose chemotherapy with stem cell support within 6 months prior to study
* Signal transduction inhibitors, monoclonal antibodies, etc. within 4 weeks prior to study
* Systemic hormonal therapy within 4 weeks prior to study
* Anticoagulant therapy, antiplatelet therapy within 2 weeks prior to study
* Radiotherapy within 4 weeks prior to study
* Significant cardiovascular disease
* Serious/active infection
* Major surgical procedures within 2 weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00310895
Study Brief:
Protocol Section:
NCT00310895